Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Lymphoid

Explore clinical trials studying Leukemia, Lymphoid. Study availability and eligibility vary by location and protocol.

3,014 public trials 549 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Lymphoid trial results

Active, Not Recruiting

Venetoclax in Addition to Blinatumomab in Adult Patients With Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL)

NCT05182385

Conditions
ALL, Recurrent, Adult, Disease Attributes, Hematologic Diseases, +15 more
Locations
  • Universitätsklinikum Tübingen Tübingen, Baden-Wurttemberg, Germany
  • Universitätsklinikum Ulm Ulm, Baden-Wurttemberg, Germany
  • University Hospital of Frankfurt (Main) Frankfurt am Main, Hesse, Germany
  • Universitätsklinikum Dresden Dresden, Saxony, Germany
View all 17 locations
View Trial Details
Active, Not Recruiting

A Study of Clinical Outcomes in Chronic Lymphocytic Leukemia (CLL) Patients Treated With Venetoclax in Greece

NCT04159779

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Henry Dunnant Hospital Center /ID# 241682 Athens, Attica, Greece
  • General Hospital of Athens Gennimatas /ID# 212917 Athens, Attica, Greece
  • General Hospital of Athens Laiko /ID# 212902 Athens, Attica, Greece
  • General Hospital of Athens Laiko /ID# 230222 Athens, Attica, Greece
View all 21 locations
View Trial Details
Active, Not Recruiting

Investigation of Remimazolam in Children Undergoing Sedation for Medical Procedures

NCT04851717

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Stanford University Palo Alto, California, United States
  • University of California Davis Children's Hospital Sacramento, California, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
  • University of Minnesota Masonic Children's Hospital Minneapolis, Minnesota, United States
View Trial Details
Active, Not Recruiting

PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

NCT03817320

Conditions
ALL, Childhood, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital Orange County Orange, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • University of Miami Miami, Florida, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

Sequential Regimen of Bendamustine Followed by Obinutuzumab (GA101), Zanubrutinib (BGB-3111) and Venetoclax (ABT-199) in Patients With Relapsed/Refractory CLL

NCT04515238

Conditions
Chronic Lymphoid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Hamatologische/Onkologische Gemeinschaftspraxis Augsburg, Germany
  • Universitätsklinik Köln Cologne, Germany
  • Onkologische Schwerpunktpraxis Esslingen am Neckar, Germany
  • Evangelische Krankenhaus Hamm Hamm, Germany
View Trial Details

Related conditions